Saving your money for next purchases
Niraparib 则乐 尼拉帕利
Niraparib (trade name in Hong Kong: Zele) is a highly effective and selective once-daily oral small molecule poly(ADP-ribose) PARP1/2 inhibitor for late-stage recurrent ovarian cancer. Maintenance therapy can significantly extend the survival period of patients with advanced ovarian cancer and reduce the recurrence of ovarian cancer.
Share:
Products
Our offers
Delivery – when you want and anywhere
A huge selection of best products
Health Classification
Let us work together to protect precious health
